Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVATION PLC Director's Dealing 2019

Dec 6, 2019

4886_dirs_2019-12-06_f941bbe0-3070-46bb-8216-986cfd70a039.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1048W

Avast PLC

06 December 2019

Avast plc

(the "Company")

6 December 2019

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

This notification is made in accordance with the requirements of the Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

ULF CLAESSON

2

Reason for the notification

a)

Position/status

NON EXECUTIVE DIRECTOR

b)

Initial notification /Amendment

INITIAL NOTIFICATION

3

Details of the issuer

a)

Name

Avast plc

b)

LEI

213800IR8G8LC2H4BO27     

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

ORDINARY SHARES OF GBP 0.10 EACH IN AVAST PLC (ISIN: GB00BDD85M81)  

b)

Nature of the transaction

SALE OF SHARES

c)

Price(s) and volume(s)

Price(s) Volume(s)
GBP 4.344087 500,000

d)

Aggregated information

- Aggregated volume - Price

Aggregated volume: 500,000 ORDINARY SHARES
Aggregated price: GBP 2,172,043.5

e)

Date of the transaction

4 December 2019

f)

Place of the transaction

LONDON STOCK EXCHANGE (XLON)

Alan Rassaby

Company Secretary

Avast Plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHQQLFBKLFBFBK